GBAS Products

Antibodies
GBAS Antibody (1B8)
GBAS Antibody (1B8)
Species: Hu, Mu, Rt, Ca, Mk
Applications: WB, IHC, IF
Host: Mouse monoclonal
GBAS Antibody
GBAS Antibody
NBP2-38984
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P
Host: Rabbit Polyclonal
GBAS Antibody
GBAS Antibody
NBP2-16617
Species: Hu, Mu
Applications: WB, IHC, IHC-P
Host: Rabbit Polyclonal
Lysates
GBAS Overexpression Lysate (N ...
GBAS Overexpression Lysate (Native)
NBL1-10993
Applications: WB
Proteins
GBAS Recombinant Protein Anti ...
GBAS Recombinant Protein Antigen
NBP2-38984PEP
Species: Hu
Applications: AC
GBAS Peptide
GBAS Peptide
NBP1-76966PEP
Species: Hu
Applications: AC
GBAS Peptide
GBAS Peptide
NBP1-77339PEP
Species: Hu
Applications: AC

Description

Chromosomal region 7p12, which contains GBAS, is amplified in approximately 40% of glioblastomas, the most common andmalignant form of central nervous system tumor.The predicted 286-amino acid protein contains a signal peptide, atransmembrane domain, and 2 tyrosine phosphorylation sites. The GBAS transcript is expressed most abundantly in heartand skeletal muscle. GBAS protein might be involved in vesicular transport. (provided by RefSeq)

Bioinformatics

Entrez Human
Uniprot Human
Human
Product By Gene ID 2631
Alternate Names
  • Glioblastoma-amplified sequence
  • NIPSNAP2NipSnap2,4-nitrophenylphosphatase domain and non-neuronal SNAP25-like 2
  • protein NipSnap homolog 2
  • glioblastoma amplified sequence

Diseases related to GBAS

Discover more about diseases related to GBAS.

Malignant Neoplasms
Neoplasms
Mitochondrial Diseases
Dementia
Glioblastoma
Alzheimer's Disease

Pathways for GBAS

View related products by pathway and learn more about each of the pathways below.

Oxidative Phosphorylation
Translation

PTMs for GBAS

Learn more about PTMs related to GBAS.

Phosphorylation

Bioinformatics Tool for GBAS

Discover related pathways, diseases and genes to GBAS. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.